Side Effects
More Side Effects
Mechanism of Action
Mechanism of Action II
Indications
100

Relatively high incidence (1:1000) of causing Steven-Johnson Syndrome 

Lamotrigine (Lamictal). More common if taken with valproate and a delayed titration schedule must be used. 

100
Acral paresthesias, word finding difficulty, weight loss 

Topiramate (Topamax) 

100

High and selective affinity for synaptic vesicle protein 2A (SV2A) in the brain, decreasing excitatory neurotransmitter release 

Briveracetam (Briviact) 

100

Agonist at 5H-2 receptors 

Fenfluramine (Fintepla) 

100

Infantile spasms 

ACTH, Vigabitran (Vigabtrin 1st line in TSC) 

200

Can cause significant hyponatremia by increasing ADH, with an incidence of 3%

Oxcarbazepine (Trileptal). Risk of hyponatremia is higher than with carbamazepine (Tegretol). 

200

Ataxia, megaloblastic anemia/blood dyscrasias, hirsutism, cerebellar atrophy, gingival hyperplasia 

Phenytoin (Dilantin) 

200

Binds to T-type voltage sensitive calcium channels, reducing exciteability 

Ethosuxamide (Zarontin) 

200

 Noncompetitive antagonist of the AMPA receptor, decreases glutamate 

Perampanel (Fycompa) 

200

Dravet 

Valproate

Clobazam, fenfluramine, and stiripentol (Diacomet) 

Cannabidiol (Epidiolex) 

Ketogenic diet 

300

Visual field cuts and progressive, permanent vision loss, despite discontinuation. 

Vigabatrin (Sabril). This risk requires baseline and q3 visual checks with ophthalmology and should be discontinued at the first sign of vision loss. 

300

Ataxia, osteoporosis, depression, contractures 

Phenobarbital 

300

Enhances the slow inactivation of sodium channels.


Lacosamide (Vimpat) 

300

Blocks sodium channels. Also, increase potassium conductance and modulate the activity of high-voltage activated calcium channels.

Oxcarbazepine (Trileptal) 

300

Lennox-Gastaut syndrome 

Valproate

Lamotrigine 

Rufinamide (Banzel) 

Basically anything else 

400

Weight gain, pancreatitis, thrombocytopenia, Alopecia, liver failure 

Valproate (Depakote). 

400

Ataxia, diplopia, PR prolongation 

Lacosamide (Vimpat) 

400

Inhibits voltage-gated sodium channels and a positive allosteric modulator of GABA. 

Cenobamate (Xcopri) 

400

Allosteric modulator of GABA receptor subunits, extends the amount of time the chloride ion channel is open. 

Phenobarbital 

400

Dravet-Avoid 

Carbamazepine, oxcarbazepine, lamotrigine, phenytoin

500

Boxed warning for causing aggression; also ataxia and weight gain 

Perampanel (Fycompa) 

500

Serotonin syndrome, valvular heart disease 

Fenfluramine (Fintepla) 

500

Decreases glutamate via blocking AMPA and kianate receptors, increases GABA receptor activity, and blocks sodium channels

Topiramate (Topamax) 

500
Modulates GABA a-2 receptor with less affinity at the a-1 receptor. 1,5 configuration. 

Clobazam (Onfi) 

500

Status epilepticus Tx (1st, 2nd 3rd and 4th line) 

BEnzodiazepine (10 mg midazolam, IM or 4 mg x 2 of lorazepam IV) 

ASM load- Keppra 60 mg/kg, Depakote 40 mg/kg, fosphenytoin/phenytoin 20 mg /kg 

ALso consider Briviact 300 mg push or lacosamide 400 mg load 

2nd ASM agent load

Sedative burst suppression with IV midazolam or ketamine->Pentobarb coma